Alijotas-Reig J, Esteve-Valverde E, Belizna C, Selva-O’Callaghan A, Pardos-Gea J, Quintana A, Mekinian A, Anunciacion-Llunell A (2020) Miró-Mur, Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review. Autoimmun Rev 19:102569. https://doi.org/10.1016/j.autrev.2020.102569

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J (1996) Human ICE/CED-3 protease nomenclature. Cell 87:171. https://doi.org/10.1016/S0092-8674(00)81334-3

Article  CAS  PubMed  Google Scholar 

Aloe L (2001) Nerve growth factor and neuroimmune responses: basic and clinical observations. Arch Physiol Biochem 109:354–356. https://doi.org/10.1076/apab.109.4.354.4235

Article  CAS  PubMed  Google Scholar 

Amorim P (2000) Mini international neuropsychiatric interview (MINI): Validação de entrevista Breve Para Diagnóstico de Transtornos Mentais. Rev Bras Psiquiatr 22:106–115. https://doi.org/10.1590/S1516-44462000000300003

Article  Google Scholar 

Anastasio F, Barbuto S, Scarnecchia E, Cosma P, Fugagnoli A, Rossi G, Colombo D (2021) Decreased circulating levels of brain-derived neurotrophic factor (BDNF) in COVID-19 patients are correlated with cognitive impairment and worse clinical outcome. J Neuroimmunol 120:689–705

Google Scholar 

Arent CO, Padilha APZ, Borba LA, de Azevedo Cardoso T, André MC, Martinello NS, Rosa T, Abelaira HM, de Moura AB, Andrade NM, Bertollo AG, de Oliveira GG, Bagatini MD, Ignácio ZM, Quevedo J, Ceretta LB, Réus GZ (2023) ABO blood type and metabolic markers in COVID-19 susceptibility and severity: a cross-sectional study. Metab Syndr Relat Disord 21:335–344. https://doi.org/10.1089/met.2023.0022

Article  CAS  PubMed  Google Scholar 

Asgarzadeh A, Fouladi N, Asghariazar V, Sarabi SF, Khiavi HA, Mahmoudi M, Safarzadeh E (2022) Serum brain-derived neurotrophic factor (BDNF) in COVID-19 patients and its association with the COVID-19 manifestations. J Mol Neurosci 72:1820–1830. https://doi.org/10.1007/s12031-022-02039-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barichello T, Kluwe-Schiavon B, Borba LA, Pedro LC, Niero FS, dos Santos LN, Leonardo LM, Ignácio ZM, Morales R, Ceretta LB, Reus GZ (2025) Alterations in gut microbiome composition and increased inflammatory markers in Post-COVID-19 individuals. Mol Neurobiol 62:8038–8047. https://doi.org/10.1007/s12035-025-04769-w

Article  CAS  PubMed  Google Scholar 

Bertollo AG, Grolli RE, Plissari ME, Gasparin VA, Quevedo J, Réus GZ, Bagatini MD, Ignácio ZM (2020) Stress and serum cortisol levels in major depressive disorder: a cross-sectional study. AIMS Neurosci 7:459–469. https://doi.org/10.3934/Neuroscience.2020028

Article  PubMed  PubMed Central  Google Scholar 

Biamonte F, Re A, Balzamino BO, Ciasca G, Santucci D, Napodano C, Nocca G, Fiorita A, Marino M, Basile U, Micera A, Callà CAM (2022) Circulating and salivary NGF and BDNF levels in SARS-CoV-2 infection: potential predictor biomarkers of COVID-19 disease—preliminary data. J Pers Med 12:1877. https://doi.org/10.3390/jpm12111877

Article  PubMed  PubMed Central  Google Scholar 

Borba LA, de Freitas Filho GA, de Azevedo Cardoso T, Arent CO, Niero FS, Pedro LC, Rodrigues CA, Cichella LR, Bagatini MD, de Oliveira GG, da Silva GB, Manica D, Ignácio ZM, Quevedo J, Ceretta LB, Réus GZ (2025) Effects of COVID-19 and medication used for treatment and symptom prevention on the antioxidant status. Pharmacol Rep 77:490–499. https://doi.org/10.1007/s43440-025-00696-8

Article  CAS  PubMed  Google Scholar 

Cacilhas AA, da Silva Magalhães PV, Ceresér KM, Walz JC, Weyne F, Rosa AR, Vieta E, Kapczinski F (2009) Validity of a short functioning test (FAST) in Brazilian outpatients with bipolar disorder. Value Health 12:624–627. https://doi.org/10.1111/j.1524-4733.2008.00481.x

Article  PubMed  Google Scholar 

Calabrese F, Molteni R, Racagni G, Riva MA (2009) Neuronal plasticity: a link between stress and mood disorders. Psychoneuroendocrinology 34:S208–S216. https://doi.org/10.1016/j.psyneuen.2009.05.014

Article  CAS  PubMed  Google Scholar 

Chen L, Li Z, Zuo L, Yang Z, Zhang Y, Zhao Y (2021) Decreased serum BDNF levels in COVID-19 patients are associated with anxiety and depression. J Affect Disord 282:165–170

Google Scholar 

da Silva GB, Manica D, da Silva AP, Valcarenghi E, Donassolo SR, Kosvoski GC, Mingoti MED, Gavioli J, Cassol JV, Hanauer MC, Hellmann MB, Marafon F, Bertollo AG, de Medeiros J, Cortez AD, Réus GZ, de Oliveira GG, Ignácio ZM, Bagatini MD (2024) Peripheral biomarkers as a predictor of poor prognosis in severe cases of COVID-19. Am J Med Sci 368:122–135. https://doi.org/10.1016/j.amjms.2024.04.011

Article  PubMed  Google Scholar 

da Silva Lopes L, Silva RO, de Sousa Lima G, de Araújo Costa AC, Barros DF, Silva-Néto RP (2021) Is there a common pathophysiological mechanism between COVID-19 and depression? Acta Neurol Belg 121:1117–1122. https://doi.org/10.1007/s13760-021-01748-5

Article  PubMed  PubMed Central  Google Scholar 

de Azevedo Cardoso T, Silva RH, Fernandes JL, Arent CO, Amboni G, Borba LA, Padilha APZ, Botelho MEM, Maciel AL, Barichello T, Morales R, Soares SJB, Bagatini MD, Dallagnol C, Brighenti ME, Ignácio ZM, Quevedo J, Ceretta LB, Réus GZ (2023) Stress levels, psychological symptoms, and C-reactive protein levels in COVID-19: a cross-sectional study. J Affect Disord 330:216–226. https://doi.org/10.1016/j.jad.2023.03.019

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Felice FG, Tovar-Moll F, Moll J, Munoz DP, Ferreira ST (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the central nervous system. Trends Neurosci 43:355–357. https://doi.org/10.1016/j.tins.2020.04.004

Article  CAS  PubMed  PubMed Central  Google Scholar 

Delorme C, Paccoud O, Kas A, Hesters A, Bombois S, Shambrook P, Boullet A, Doukhi D, Le Guennec L, Godefroy N, Maatoug R, Fossati P, Millet B, Navarro V, Bruneteau G, Demeret S, Pourcher V (2020) COVID-19‐related encephalopathy: a case series with brain FDG‐positron‐emission tomography/computed tomography findings. Eur J Neurol 27:2651–2657. https://doi.org/10.1111/ene.14478

Article  CAS  PubMed  Google Scholar 

Derogatis LR (1975) SCL-90-R: symptom Checklist-90-R: administration, scoring, and procedures manual. NCS Pearson

Desforges M, Le Coupanec A, Brison É, Meessen-Pinard M, Talbot PJ (2012) Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans, in: Infectious Diseases and Nanomedicine I: First International Conference (ICIDN–2012), Dec. 15–18, Kathmandu, Nepal, Springer, 2014: pp. 75–96

Donia A, Bokhari H (2021) Apoptose induzida por SARS-CoV-2: podemos abordá-la? Apoptose 7–8

Drzyzga ŁR, Marcinowska A, Obuchowicz E (2009) Antiapoptotic and neurotrophic effects of antidepressants: a review of clinical and experimental studies. Brain Res Bull 79:248–257. https://doi.org/10.1016/j.brainresbull.2009.03.009

Article  CAS  PubMed  Google Scholar 

Duman RS, Monteggia LM (2006) A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59:1116–1127. https://doi.org/10.1016/j.biopsych.2006.02.013

Article  CAS  PubMed  Google Scholar 

Edén A, Kanberg N, Gostner J, Fuchs D, Hagberg L, Andersson L-M, Lindh M, Price RW, Zetterberg H, Gisslén M (2021) CSF biomarkers in patients with COVID-19 and neurologic symptoms. Neurology 96. https://doi.org/10.1212/WNL.0000000000010977

Generoso JS, Barichello de Quevedo JL, Cattani M, Lodetti BF, Sousa L, Collodel A, Diaz AP (2021) Dal-Pizzol, neurobiology of COVID-19: how can the virus affect the brain? Brazilian J Psychiatry 43:650–664

Article  Google Scholar 

Giglio LMF, Magalhães PV, Andreazza AC, Walz JC, Jakobson L, Rucci P, Rosa AR, Hidalgo MP, Vieta E, Kapczinski F (2009) Development and use of a biological rhythm interview. J Affect Disord 118:161–165. https://doi.org/10.1016/j.jad.2009.01.018

Article  PubMed  Google Scholar 

Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32:50-55. https://doi.org/10.1111/j.2044-8341.1959.tb00467.x

Article  PubMed  Google Scholar 

Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278–296. https://doi.org/10.1111/j.2044-8260.1967.tb00530.x

Article  CAS  PubMed  Google Scholar 

Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu N-H, Nitsche A, Müller MA, Drosten C, Pöhlmann S (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:271-280e8. https://doi.org/10.1016/j.cell.2020.02.052

Article  PubMed  PubMed Central  Google Scholar 

Hu Y, Chen Y, Zheng Y, You C, Tan J, Hu L, Zhang Z, Ding L (2020) Factors related to mental health of inpatients with COVID-19 in Wuhan, China. Brain Behav Immun 89:587–593. https://doi.org/10.1016/j.bbi.2020.07.016

Article  CAS  PubMed